针刺对COPD稳定期患者肺功能和生命质量影响疗效评价

Comparative Research on Effect of Acupuncture on Pulmonary Function and Life Quality of Patients with Chronic Obstructive Pulmonary Disease in Stable Phase

目的观察针刺对慢性阻塞性肺病稳定期(COPD)患者肺功能的影响,比较其对患者临床症状、生命质量及呼吸困难的改善作用。方法将61例患者随机分为针刺组(31例)和舒利迭组(30例)。针刺组穴取定喘、肺俞、足三里为主,毫针针刺,隔日1次,每周3次;舒利迭组予舒利迭吸入剂治疗,每次1吸,每天2次。均治疗8周,观察两组病例治疗后的1s用力呼气量(FEV1)等肺功能指标改变、临床症状、圣乔治呼吸问卷(SGRQ)的评分,进行组间和组内的比较。结果针刺和舒利迭组均有效改善FEV1等肺功能指标(均<0.05);治疗4周后对呼吸道症状的改善舒利迭组优于针刺组(<0.05),治疗8周后两组效能相当(>0.05);对生命质量的改善针刺组稍优于舒利迭组(改善值11.57±5.24 vs 9.89±4.76,<0.05)。结论针刺能起到改善COPD稳定期患者肺功能的作用,缓解临床症状,提高生命质量,其效能与舒利迭治疗相当。

Objective To observe the effect of acupuncture on the lung function of patients with chronic obstructive pulmonary disease（COPD） in the stable phase and to compare the effect of acupuncture on the improvement of clinical symptoms,quality of life,and dyspnea of patients. Methods 61 cases of patients were randomly divided into acupuncture group（31 cases）and seretide group（30 cases）. Dingchuan,Feishu and Zusanli were applied as the main points for every other day,3 times per week;seretide inhaler treatment was applied in seretide group for 1 inhalation each time,twice a day. All patients were treated for 8 weeks. Changes in lung function parameters such as 1 second forced expiratory volume（FEV1） after treatment,clinical symptoms,and St. George＇s Respiratory Questionnaire（SGRQ） were observed between groups and within groups. Results FEV1 and other pulmonary function indexes was improved both groups（P〈0.05）. After 4 weeks of treatment,the improvement of respiratory symptoms in seretide group was better than that of acupuncture group（P〈0.05）,after 8 weeks of treatment,the efficacy of the two groups was comparable（P〉0.05）;the improvement of the quality of life was slightly better in acupuncture group than in seretide group（improved value： 11.57±5.24 vs 9.89±4.76,P〈0.05）. Conclusion Acupuncture can improve the function of COPD in patients with stable lung function,relieve clinical symptoms and improve the quality of life. Its efficacy is similar to that of seretide.